USP posts the status of Revisions, Deferrals, Cancellations, Commentary, and Index for each USP–NF and Supplement.
- Revisions are approved standards that will appear in the publication.
- Deferrals are items that have been proposed in Pharmacopeial Forum (PF) but are not yet approved by an Expert Committee.
- Cancellations are items that have been proposed in PF but have been canceled. Canceled items may be re-proposed in a future PF.
- Commentary is a summary of comments received and the appropriate Expert Committee's responses in cases when proposals advance to official status without being re-published in PF.
- The Index is a copy of the combined Index for a given Book or Supplement. The Index is posted for informational use only and should not be used for interpretive purposes.
Revisions, Deferrals, and Cancellations generally are posted in advance of posting of the online USP–NF or Supplement. Commentary and Index are posted the same day the online USP–NF, Supplement, or other official text is released.
Now Available: 2015–2020 Cumulative List of USP–NF Revisions (updated 25–Sep–2020)
The Cumulative List of USP–NF Revisions provides updated information on all items approved, deferred, or cancelled during the 2015–2020 Cycle.
Interim Revision Announcements
As of First Supplement to USP 43–NF 38, IRAs are no longer associated with a print publication and are immediately available on USP–NF Online.
IRAs published in PF 46(3)
- Deferrals: General Notices
- Cancellations: None
- Commentary for IRAs posted on September 25, 2020 (updated 14–Oct–2020)
- Cetyl Alcohol
- Stearyl Alcohol
- Telmisartan and Amlodipine Tablets
IRAs published in PF 46(2)
- Deferrals: Paroxetine Hydrochloride
- Cancellations: None
- Commentary for IRAs posted on July 31, 2020
- <7> Labeling
- Temozolomide
- Temozolomide Capsules
- Temozolomide for Injection
- Travoprost Ophthalmic Solution
IRAs published in PF 46(1)
No new IRAs were published for comment in PF 46(1)
IRAs published in PF 45(6)
- Deferrals: <7> Labeling
- Cancellations: None
- Commentary for IRAs posted on March 27, 2020
- Goserelin Acetate
- Zolmitriptan
IRAs published in PF 45(5)
- No new IRAs were published for comment in PF 45(5)
IRAs published in PF 45(4)
- No new IRAs were published for comment in PF 45(4)
- Commentary for IRAs posted on November 22, 2019
- Formoterol Fumarate
IRAs published in 45(3)
- Deferrals: Formoterol Fumarate
- Cancellations: None
- Commentary for IRAs posted on September 27, 2019
- <467> Residual Solvents
- Atropine Sulfate Ophthalmic Solution
IRAs published in 45(2):
- Deferrals: Atropine Sulfate Ophthalmic Solution
- Cancellations: None
- Commentary: None
IRAs published in 45(1):
- Deferrals: Glycine
- Cancellations: None
- Commentary: None
USP 2021, Issue 1
- Deferrals (posted 25–Sep–2020)
- Cancellations (posted 25–Sep–2020)
- Revisions (posted 25–Sep–2020)
USP 43–NF 38
Supplement 2
- Revisions (posted 24–Apr–2020)
- Deferrals (posted 24–Apr–2020)
- Cancellations (posted 24–Apr–2020)
- Commentary (posted 01–Jun–2020)
Supplement 1
Due to the extended comment period for Pharmacopeial Forum 45(1), it will be included in the publication for Supplement 1 instead of that for USP–NF.
- Revisions (posted 26–Dec–2019)
- Deferrals (posted 26–Dec–2019)
- Cancellations (posted 26–Dec–2019)
- Commentary (posted 03–Feb–2020; revised 05–Feb–2020)
Book
- Revisions (posted 26–Jul–2019)
- Deferrals (posted 26–Jul–2019)
- Cancellations (posted 26–Jul–2019)
- Commentary (posted 01–Nov–2019)
- Index (posted 01–Nov–2019)
IRAs published in 44(6)
- There were no IRAs published for comment in 44(6)